American Battery Technology Company (NASDAQ:ABAT) Stock Price Slipped -0.96% to $1.03
Northland Capital raised the price target for the American Battery Technology Company (NASDAQ:ABAT) stock to “an Outperform”. The rating was released on March 27, 2024, according to finviz. The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated -12.71% within the last five trades and -27.46% within the […]
Consensus Analyst Estimated Price Target of $2.79 for Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) Stock
Scotiabank raised the price target for the Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) stock to “a Sector outperform”. The rating was released on May 30, 2024, according to finviz. The research report from Guggenheim has upgraded the stock from Neutral to Buy, with a price target set at $5. The stock was upgraded by Mizuho, who […]
Why Tarsus Pharmaceuticals Inc (NASDAQ:TARS) Stock went up 42.05% in Last Year?
Goldman raised the price target for the Tarsus Pharmaceuticals Inc (NASDAQ:TARS) stock to “a Neutral”. The rating was released on November 20, 2023, according to finviz. The stock was initiated by Barclays, who disclosed in a research note on August 01, 2022, to Overweight and set the price objective to $40. In their research brief […]
MaxCyte Inc (NASDAQ:MXCT) Stock is trading Higher 0.66% From 200-Day SMA
Craig Hallum raised the price target for the MaxCyte Inc (NASDAQ:MXCT) stock to “a Buy”. The rating was released on November 29, 2023, according to finviz. The stock was initiated by Wedbush, who disclosed in a research note on August 24, 2021, to Outperform and set the price objective to $36. In their research brief […]
Analysts Rating: Silvaco Group Inc. (NASDAQ:SVCO) Stock Won “a Buy” Rating From B. Riley Securities
B. Riley Securities raised the price target for the Silvaco Group Inc. (NASDAQ:SVCO) stock to “a Buy”. The rating was released on June 05, 2024, according to finviz. The research report from TD Cowen has initiated the stock to Buy, with a price target set at $23. The stock was initiated by Rosenblatt, who disclosed […]
Why BioVie Inc (NASDAQ:BIVI) Stock down -3.43% in Last Week?
Cantor Fitzgerald raised the price target for the BioVie Inc (NASDAQ:BIVI) stock to “an Overweight”. The rating was released on July 22, 2022, according to finviz. The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated -3.43% within the last five trades and -2.94% within the last 30 […]
Lion Electric Co (NYSE:LEV) stock Reported Profit Margin of -43.21 percent in Last Year: Is Defensible?
National Bank Financial raised the price target for the Lion Electric Co (NYSE:LEV) stock from “an Outperform” to “a Sector perform”. The rating was released on August 04, 2023, according to finviz. The research report from BMO Capital Markets has initiated the stock to Market Perform, with a price target set at $2. The stock […]
B. Riley Securities Assigned “a Neutral” Rating to Applied Optoelectronics Inc (NASDAQ:AAOI) Stock
B. Riley Securities lowered the price target for the Applied Optoelectronics Inc (NASDAQ:AAOI) stock from “a Buy” to “a Neutral”. The rating was released on February 23, 2024, according to finviz. The research report from B. Riley Securities has reiterated the stock to Buy, with a price target set at $22. The stock was upgraded […]
Mersana Therapeutics Inc (NASDAQ:MRSN) stock is trading 165.78 percent above its 52-week low
JP Morgan raised the price target for the Mersana Therapeutics Inc (NASDAQ:MRSN) stock from “an Underweight” to “a Neutral”. The rating was released on March 19, 2024, according to finviz. We previously noted in another research note published on February 29, 2024 by Wedbush that upgraded the stock from a Neutral to an Outperform with […]
Akebia Therapeutics Inc. (NASDAQ:AKBA) Stock is trading Below -25.99% From 50-Day SMA
BTIG Research raised the price target for the Akebia Therapeutics Inc. (NASDAQ:AKBA) stock to “a Buy”. The rating was released on November 29, 2023, according to finviz. The research report from Piper Sandler has upgraded the stock from Neutral to Overweight, with a price target set at $4. The stock was downgraded by Piper Sandler, […]
